Data / Research funding / Ohio / Cleveland Clinic Lerner Com-Cwru
Cleveland Clinic Lerner Com-Cwru: 448 NIH awards ($615.7M), fiscal years 2021 to 2026
Cleveland Clinic Lerner Com-Cwru in Cleveland, OH is funded under 448 NIH awards ($615.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- M5QFLTCTSQN6
- State
- Ohio
Awards
448 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Cleveland Alzheimers Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $15,367,621 | September 1, 2021 | June 30, 2027 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Cell Adhesion and Signaling in Blood and Vascular Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,074,218 | September 1, 2021 | November 30, 2026 | QIN, JUN | reporter.nih.gov |
| Atrial Fibrillation Post-GWAS: Mechanisms to Treatment | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $11,309,762 | July 1, 2022 | June 30, 2027 | CHUNG, MINA KAY | reporter.nih.gov |
| Alcohol and tissue injury, from mechanisms to treatments | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,342,740 | May 1, 2016 | March 31, 2026 | NAGY, LAURA E. | reporter.nih.gov |
| Sex-based Differences in Glioma | NIH | National Cancer Institute | 2021 to 2025 | $8,258,328 | September 14, 2020 | December 31, 2026 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment | NIH | National Cancer Institute | 2022 to 2025 | $7,530,252 | September 13, 2022 | August 31, 2027 | STARK, GEORGE ROBERT | reporter.nih.gov |
| CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,389,501 | January 15, 2021 | December 31, 2026 | RAO, STEPHEN MARK | reporter.nih.gov |
| Gut Microbiota and Cardiometabolic Diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $7,273,070 | September 1, 2019 | July 31, 2025 | HAZEN, STANLEY L | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,563,373 | September 30, 2016 | August 31, 2027 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies | NIH | National Cancer Institute | 2022 to 2025 | $6,280,793 | September 14, 2022 | July 31, 2027 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients | NIH | National Institute on Aging | 2022 to 2025 | $5,979,214 | August 1, 2022 | June 30, 2027 | ROTHBERG, MICHAEL B | reporter.nih.gov |
| Defining the viral PTMome: Towards the development of novel antiviral approaches | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,635,000 | September 30, 2021 | July 31, 2026 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,233,917 | July 1, 2020 | June 30, 2026 | ONTANEDA, DANIEL | reporter.nih.gov |
| Assessing Novel Biomarkers for Cognitive Fluctuations in DLB | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $4,924,374 | September 1, 2025 | July 31, 2029 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery | NIH | National Institute on Aging | 2021 to 2025 | $3,966,759 | September 1, 2021 | August 31, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance | NIH | National Cancer Institute | 2021 to 2024 | $3,811,506 | May 1, 2020 | August 31, 2025 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Variation in tumor-associated immune profiles and colorectal cancer outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,497,316 | September 15, 2021 | August 31, 2027 | SCHMIT, STEPHANIE L. | reporter.nih.gov |
| Pathogenesis of Neurological Disability in Primary Diseases of Myelin | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,460,848 | December 1, 2016 | November 30, 2025 | TRAPP, BRUCE D | reporter.nih.gov |
| BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $3,403,884 | August 1, 2018 | July 31, 2025 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Cleveland COPE-AKI Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,307,197 | July 19, 2021 | June 30, 2028 | POGGIO, EMILIO DANIEL | reporter.nih.gov |
| Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,276,651 | September 23, 2021 | July 31, 2027 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,240,062 | July 15, 2022 | March 31, 2027 | CHENG, FEIXIONG | reporter.nih.gov |
| A Cognitive Risk Calculator and Screening tool for Primary Care Settings | NIH | National Institute on Aging | 2022 to 2024 | $3,228,752 | September 30, 2020 | August 31, 2025 | FLODEN, DARLENE | reporter.nih.gov |
| NEI Center Core Grant for Vision Research | NIH | National Eye Institute | 2021 to 2025 | $3,220,006 | September 1, 2016 | June 30, 2026 | ANAND-APTE, BELA | reporter.nih.gov |
| Imaging post-traumatic osteoarthritis 10-years after ACL reconstruction: a multicenter cohort study with quantitative MRI | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $3,194,922 | July 16, 2019 | June 30, 2025 | LI, XIAOJUAN | reporter.nih.gov |
| Complement regulates macrophage and platelet function in kidney transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,127,980 | September 17, 2021 | August 31, 2026 | BALDWIN, WILLIAM M | reporter.nih.gov |
| Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2024 | $3,070,887 | April 15, 2020 | December 31, 2025 | CHENG, FEIXIONG | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Therapeutic Implications of Molecular Defects in Bone Marrow Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,016,565 | January 12, 2017 | December 31, 2023 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Mechanisms of alloantibody production following renal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,014,441 | February 22, 2021 | January 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms | NIH | National Cancer Institute | 2021 to 2025 | $2,986,870 | July 1, 2021 | June 30, 2026 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Optimizing Lung Transplant Benefit Using Agent-Based Simulation Modeling Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,960,354 | June 1, 2020 | April 30, 2029 | VALAPOUR, MARYAM | reporter.nih.gov |
| RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,935,937 | July 15, 2021 | June 30, 2025 | CHUNG, MINA KAY | reporter.nih.gov |
| Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,931,322 | May 1, 2020 | April 30, 2027 | LI, XIAOJUAN | reporter.nih.gov |
| Cardiothoracic Surgical Trials Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,925,675 | July 1, 2007 | February 28, 2027 | GILLINOV, ALAN MARC | reporter.nih.gov |
| Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,890,525 | December 1, 2024 | November 30, 2026 | SCOTT, JACOB GARDINIER | reporter.nih.gov |
| Discovering the role of YES1 in triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,805,224 | February 1, 2021 | January 31, 2027 | KERI, RUTH A. | reporter.nih.gov |
| Intracellular functions of APOL1 in the kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,802,067 | September 23, 2021 | May 31, 2026 | BRUGGEMAN, LESLIE A | reporter.nih.gov |
| Gut Flora metabolism of dietary carnitine and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,763,113 | August 1, 2010 | April 30, 2026 | HAZEN, STANLEY L | reporter.nih.gov |
| New mouse model of cisplatin-induced AKI and development of prevention therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,680,156 | August 1, 2021 | July 31, 2026 | ZHAO, JIANJUN | reporter.nih.gov |
| 1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,676,312 | March 15, 2020 | February 28, 2026 | MCCRAE, KEITH R. | reporter.nih.gov |
| Identifying novel Parkinson'Âs disease genes exploring understudied Latino populations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,667,664 | August 1, 2020 | July 31, 2025 | FERNANDEZ MATA, IGNACIO | reporter.nih.gov |
| Optimization of CaMPARI for large-scale, cellular-resolution activity recording in freely-moving mice | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,646,453 | September 1, 2021 | December 31, 2026 | DANA, HOD MICHAEL | reporter.nih.gov |
| Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,608,897 | August 15, 2022 | May 31, 2027 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,568,308 | September 30, 2020 | August 31, 2025 | ROTROFF, DANIEL | reporter.nih.gov |
| Chronic Antibody-Mediated Rejection of Kidney Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,566,057 | February 1, 2022 | January 31, 2027 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Platelets as Biosensors and Mediators of Aortic Aneurysm Growth | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,499,163 | July 1, 2021 | June 30, 2027 | CAMERON, SCOTT JAMES | reporter.nih.gov |
| FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy. | NIH | National Eye Institute | 2021 to 2024 | $2,497,198 | April 1, 2017 | March 31, 2026 | ANAND-APTE, BELA | reporter.nih.gov |
| Genetic modifiers of atherosclerosis and macrophage phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,457,383 | July 1, 2021 | June 30, 2026 | SMITH, JONATHAN D | reporter.nih.gov |
| Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery | NIH | National Eye Institute | 2022 to 2025 | $2,454,968 | July 1, 2022 | June 30, 2027 | DUPPS, WILLIAM JOSEPH | reporter.nih.gov |
| Post-Transplant Inflammatory Response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,437,884 | April 1, 1997 | November 30, 2029 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Clinical Center-Cleveland site | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,432,868 | June 15, 2002 | June 30, 2027 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Comprehensive Augmented Reality Testing (CART) Platform for Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,416,358 | September 1, 2022 | July 31, 2027 | ALBERTS, JAY L. | reporter.nih.gov |
| High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,415,000 | September 30, 2021 | July 31, 2027 | WESSELY, OLIVER | reporter.nih.gov |
| Designing induction therapies to target memory T cells in high risk recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,405,990 | July 15, 2014 | August 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Model-based methods for single cell chromatin interactomic data | NIH | National Human Genome Research Institute | 2021 to 2025 | $2,402,915 | September 22, 2021 | June 30, 2027 | HU, MING | reporter.nih.gov |
| Iron Dysregulation and Neuropsychiatric Complications of HIV Across the Lifespan: Impact of Biologic Factors, Antiretroviral Therapy and Genetics | NIH | National Institute of Mental Health | 2021 to 2025 | $2,401,925 | March 1, 2021 | December 31, 2025 | KALLIANPUR, ASHA R | reporter.nih.gov |
| Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,398,824 | May 1, 2022 | April 30, 2030 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing | NIH | National Institute on Aging | 2023 | $2,394,473 | May 15, 2023 | April 30, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches | NIH | National Institute on Aging | 2023 to 2025 | $2,391,375 | September 1, 2023 | May 31, 2028 | CHENG, FEIXIONG | reporter.nih.gov |
| The role of hippocampal neurogenesis in alcohol withdrawal seizure and cognition | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $2,379,308 | April 10, 2020 | March 31, 2026 | SUH, HOONKYO | reporter.nih.gov |
| Unraveling strain-level variation in the induction of anti-inflammatory responses in the intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,378,553 | January 1, 2021 | December 31, 2026 | AHERN, PHILIP PATRICK | reporter.nih.gov |
| Manipulation of host factors that promote HCMV latency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,372,365 | March 15, 2021 | February 28, 2027 | O'CONNOR, CHRISTINE M | reporter.nih.gov |
| Sensing active movement of the self: reconsidering the cellular basis kinesthesia | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,365,503 | May 6, 2022 | January 31, 2027 | MARASCO, PAUL D. | reporter.nih.gov |
| Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral Regurgitation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,357,020 | July 10, 2023 | April 30, 2028 | KWON, DEBORAH | reporter.nih.gov |
| Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,344,291 | August 18, 2023 | July 31, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,343,205 | September 14, 2017 | February 28, 2027 | FARRELL, RUTH | reporter.nih.gov |
| Machine and deep learning for finding multimodal imaging biomarkers in prodromal AD | NIH | National Institute on Aging | 2021 | $2,331,558 | April 1, 2021 | March 31, 2024 | CORDES, DIETMAR | reporter.nih.gov |
| Reassortment of Bunyavirus in ticks and animal models | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,326,633 | August 19, 2022 | July 31, 2027 | JUNG, JAE U | reporter.nih.gov |
| Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE) | NIH | National Cancer Institute | 2022 to 2025 | $2,315,714 | April 1, 2022 | March 31, 2027 | CREMER, MIRIAM | reporter.nih.gov |
| Nitric Oxide in Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,291,952 | April 1, 1999 | December 31, 2025 | ERZURUM, SERPIL C. | reporter.nih.gov |
| Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,281,556 | September 22, 2021 | August 31, 2026 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,277,916 | September 20, 2021 | August 31, 2025 | MCINTYRE, THOMAS M | reporter.nih.gov |
| Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $2,270,781 | September 1, 2022 | May 31, 2028 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| SFTSV nonstructural protein NSs-mediated immunopathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,260,994 | July 1, 2018 | June 30, 2024 | JUNG, JAE U | reporter.nih.gov |
| Tickborne SFTS Virus Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,258,000 | August 3, 2020 | July 31, 2026 | JUNG, JAE U | reporter.nih.gov |
| AS160 as a nodal regulator of the cardiac response to metabolic stress | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,241,409 | August 1, 2022 | July 31, 2027 | SCHUMACHER, SARAH MARIE | reporter.nih.gov |
| Regulation of Host Innate Immunity Against Viral Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,230,417 | April 1, 2010 | May 31, 2026 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling | NIH | National Cancer Institute | 2023 to 2025 | $2,229,645 | August 1, 2023 | July 31, 2028 | SCOTT, JACOB GARDINIER | reporter.nih.gov |
| Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $2,223,387 | September 25, 2020 | July 31, 2025 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Gut-microbial metabolism of aromatic amino acids and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,221,265 | December 15, 2021 | November 30, 2026 | NEMET, INA | reporter.nih.gov |
| Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial | NIH | National Institute of Nursing Research | 2022 to 2025 | $2,209,310 | September 26, 2022 | June 30, 2027 | MCGINLEY, MARISA | reporter.nih.gov |
| Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,201,245 | April 1, 2021 | March 31, 2026 | BERKNER, KATHLEEN LUCILE | reporter.nih.gov |
| Improving intracortical control of reaching after paralysis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,197,457 | July 1, 2020 | June 30, 2026 | TAYLOR, DAWN MARIE | reporter.nih.gov |
| lncRNA regulation of glioblastoma progression and therapeutic resistance | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,168,484 | December 1, 2021 | November 30, 2026 | YU, JENNIFER S | reporter.nih.gov |
| HCMV GPCR functions during latency and reactivation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,168,053 | March 18, 2021 | February 28, 2027 | O'CONNOR, CHRISTINE M | reporter.nih.gov |
| Mechanisms of cancer immunotherapy-associated thrombosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,146,502 | April 15, 2023 | March 31, 2027 | MCCRAE, KEITH R. | reporter.nih.gov |
| Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults | NIH | National Institute on Aging | 2021 to 2023 | $2,132,124 | July 1, 2019 | April 30, 2025 | TAKSLER, GLEN | reporter.nih.gov |
| Metaorganismal Endocrinology in Cardiometabolic Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,105,517 | August 13, 2021 | May 31, 2026 | BROWN, JONATHAN MARK | reporter.nih.gov |
| TRPV4 Regulates Mechanosensitive Macrophage Functions in Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,097,481 | February 1, 2021 | January 31, 2027 | SCHERAGA, RACHEL GREENBERG | reporter.nih.gov |
| Impact of gamma-glutamyl carboxylase processivity on vitamin K-dependent protein modification and function in human health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,096,222 | August 1, 2021 | May 31, 2025 | BERKNER, KATHLEEN LUCILE | reporter.nih.gov |
| A place-based approach to geographic disparities in lung transplant | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,075,369 | August 1, 2023 | May 31, 2028 | TSUANG, WAYNE M | reporter.nih.gov |
| Alcohol and intestinal microvascular endothelium-immune axis and the role of gut derived immune nutrients | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $2,049,465 | September 1, 2020 | July 31, 2026 | CRESCI, GAIL ANN | reporter.nih.gov |
| Systemic Neurotropic virus infection effects on GI Dysmotility | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,043,482 | July 1, 2020 | April 30, 2025 | STAPPENBECK, THADDEUS S | reporter.nih.gov |
| A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,033,135 | September 24, 2022 | August 31, 2025 | CHENG, JIANGUO | reporter.nih.gov |
| Deep Brain Stimulation of the Cerebellar Dentate Nucleus to Enhance Chronic, Post-Traumatic Brain Injury Rehabilitation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,019,158 | July 1, 2020 | June 30, 2026 | BAKER, KENNETH B | reporter.nih.gov |
| Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis | NIH | National Eye Institute | 2022 to 2025 | $2,018,294 | September 1, 2021 | June 30, 2027 | LIN, PHOEBE | reporter.nih.gov |
| Uncovering aryl polyene biology to identify new drug targets in Gram-negative bacterial pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,012,500 | April 1, 2021 | March 31, 2027 | CLAESEN, JAN | reporter.nih.gov |
| Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,007,027 | July 15, 2022 | April 30, 2027 | IVANOV, ANDREI IVANOVICH | reporter.nih.gov |
| Mechanisms of Kidney Diseases Associated With APOL1 Variation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,973,997 | February 2, 2023 | December 31, 2026 | SEDOR, JOHN R. | reporter.nih.gov |
| Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor | NIH | National Cancer Institute | 2021 to 2024 | $1,963,648 | September 4, 2020 | May 31, 2026 | JUNG, JAE U | reporter.nih.gov |
| Clinical genetics of drug-resistant epilepsy with focal cortical dysplasia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,963,087 | April 15, 2021 | June 30, 2023 | LAL, DENNIS | reporter.nih.gov |
| Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study | NIH | National Cancer Institute | 2024 to 2025 | $1,962,036 | September 19, 2024 | August 31, 2029 | JUNG, JAE U | reporter.nih.gov |
| Immuno-metabolic dysfunction in alcohol with sepsis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,961,505 | September 20, 2021 | July 31, 2027 | VACHHARAJANI, VIDULA | reporter.nih.gov |
| The role of the astrocyte immunoproteasome during chronic CNS autoimmunity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,960,175 | December 1, 2020 | November 30, 2026 | WILLIAMS, JESSICA L | reporter.nih.gov |
| Using patient-level decision modeling to improve use of treatments for alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,949,796 | September 15, 2023 | June 30, 2028 | LE, PHUC | reporter.nih.gov |
| Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease | NIH | National Institute on Aging | 2021 | $1,943,194 | May 1, 2003 | May 31, 2023 | RAO, STEPHEN MARK | reporter.nih.gov |
| Developing a renewable and dissectible human liver for the study of HBV/HCV infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,932,000 | August 18, 2022 | July 31, 2027 | WU, XIANFANG | reporter.nih.gov |
| Novel approaches to improve prediction of cancer-associated thrombosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,925,190 | August 1, 2018 | July 31, 2025 | MCCRAE, KEITH R. | reporter.nih.gov |
| Molecular basis of ILK-mediated cell adhesion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,905,818 | January 1, 1999 | March 31, 2028 | QIN, JUN | reporter.nih.gov |
| Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,900,437 | December 15, 2022 | November 30, 2026 | PRASAD, SATHYAMANGLA V | reporter.nih.gov |
| The role of NUDT16 in DNA damage response and tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $1,900,364 | December 1, 2018 | July 31, 2029 | GONG, ZIHUA | reporter.nih.gov |
| Adipokines, Aging, and Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2024 | $1,897,892 | June 15, 2020 | March 31, 2025 | FOX, PAUL L | reporter.nih.gov |
| Activity and connectivity of hippocampal newborn neurons underlie alcohol withdrawal-associated syndromes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,897,725 | August 15, 2023 | May 31, 2028 | SUH, HOONKYO | reporter.nih.gov |
| The mammalian multi-tRNA synthetase complex | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,880,219 | December 1, 2021 | November 30, 2026 | FOX, PAUL L | reporter.nih.gov |
| Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Randomized Placebo Controlled Trial | NIH | National Institute of Mental Health | 2021 to 2025 | $1,869,024 | September 15, 2020 | August 31, 2026 | FALCONE, TATIANA | reporter.nih.gov |
| Septins in intestinal fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,865,031 | May 1, 2023 | April 30, 2027 | RIEDER, FLORIAN | reporter.nih.gov |
| Childhood-onset hypomyelinating leukodystrophy and the multi-tRNA synthetase complex | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,861,106 | December 15, 2022 | November 30, 2027 | FOX, PAUL L | reporter.nih.gov |
| Digital Twin Neighborhoods for Research on Geographic Patterns in Mid-Life Health Trajectories | NIH | National Institute on Aging | 2023 to 2025 | $1,854,705 | January 1, 2023 | December 31, 2027 | DALTON, JARROD | reporter.nih.gov |
| Interactions of Sex and Gender Factors in Risk for Alzheimers Disease: Links Between Stress, Neural Activity, Inflammation, and Memory | NIH | National Institute on Aging | 2021 to 2024 | $1,849,427 | August 1, 2021 | April 30, 2026 | KIRKLAND CALDWELL, JESSICA | reporter.nih.gov |
| Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinsons Disease Using Real-Time Neural Control | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,831,432 | July 1, 2023 | June 30, 2028 | ESCOBAR SANABRIA, DAVID | reporter.nih.gov |
| Serial evaluation of cardioprotective effects of exercise training in heart failure using cardiac diffusion tensor MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,817,778 | November 4, 2022 | May 31, 2026 | NGUYEN, CHRISTOPHER T | reporter.nih.gov |
| Reproducibility in simulation-based prediction of natural knee mechanics | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,817,682 | September 1, 2023 | August 31, 2027 | ERDEMIR, AHMET | reporter.nih.gov |
| Contralaterally Controlled FES Combined with Brain Stimulation for Severe Upper limb Hemiplegia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,815,195 | May 1, 2019 | April 30, 2026 | PLOW, ELA B | reporter.nih.gov |
| The role of acetogenic, methanogenic, and sulfate-reducing bacteria in oxalate metabolism and hyperoxaluria | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,811,784 | April 17, 2020 | February 28, 2026 | MILLER, AARON W | reporter.nih.gov |
| Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins | NIH | National Cancer Institute | 2021 to 2024 | $1,811,473 | May 1, 2021 | April 30, 2025 | SCHMIT, STEPHANIE L. | reporter.nih.gov |
| The Role of TRIM23 in Autophagy Mediated Antiviral Defenses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,809,998 | June 1, 2020 | May 31, 2025 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Mechanisms of nuclear Mcl-1 mediated chemoresistance | NIH | National Cancer Institute | 2021 to 2025 | $1,808,294 | December 4, 2020 | November 30, 2025 | MELENHORST, JAN J | reporter.nih.gov |
| IRAKM and MINCLE in ALD | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,806,489 | August 17, 2023 | July 31, 2028 | NAGY, LAURA E. | reporter.nih.gov |
| Understanding role of circadian disruption in pathogenesis of MS | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,795,603 | March 1, 2022 | February 28, 2027 | DUTTA, RANJAN | reporter.nih.gov |
| KUH-TN Training Core | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,765,732 | September 15, 2021 | May 31, 2027 | STAVROU, EVI X. | reporter.nih.gov |
| Transcriptional and non-transcriptional function of IRF3 in ALD | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,763,975 | July 5, 2019 | June 30, 2029 | NAGY, LAURA E. | reporter.nih.gov |
| Understanding and Using Variation in Source Materials for MSC Fabrication | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,762,373 | August 14, 2019 | April 30, 2025 | MUSCHLER, GEORGE F | reporter.nih.gov |
| CYClical Lower Extremity exercise for Parkinsons trial (CYCLE Trial) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,752,215 | September 1, 2011 | April 30, 2026 | ALBERTS, JAY L. | reporter.nih.gov |
| Molecular Basis of KSHV oncogenesis | NIH | National Cancer Institute | 2021 to 2022 | $1,726,428 | March 1, 2016 | February 28, 2023 | JUNG, JAE U | reporter.nih.gov |
| Combined Training Program in Digestive Disease Sciences | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,723,447 | July 1, 2009 | March 31, 2027 | FIOCCHI, CLAUDIO | reporter.nih.gov |
| KSHV Epigenetic Regulation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,716,021 | September 15, 2020 | November 30, 2024 | JUNG, JAE U | reporter.nih.gov |
| Cleveland Precision Medicine Chronic Kidney Disease Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,690,576 | September 15, 2017 | June 30, 2027 | O'TOOLE, JOHN F. | reporter.nih.gov |
| Software for Practical Annotation and Exchange of Virtual Anatomy | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $1,689,780 | July 2, 2019 | March 31, 2025 | ERDEMIR, AHMET | reporter.nih.gov |
| Two novel threonine phosphorylations of STAT2 impact inflammatory responses to bacterial infection. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,687,938 | August 7, 2020 | July 31, 2024 | STARK, GEORGE ROBERT | reporter.nih.gov |
| Inflammatory Signaling and Regeneration in Zebrafish models of Retinal Degeneration | NIH | National Eye Institute | 2023 to 2025 | $1,676,798 | September 1, 2023 | January 31, 2027 | PERKINS, BRIAN D | reporter.nih.gov |
| A novel regulator of Pseudomonas aeruginosa keratitis | NIH | National Eye Institute | 2021 to 2023 | $1,662,832 | May 1, 2020 | April 30, 2026 | LIN, FENG C | reporter.nih.gov |
| Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease | NIH | National Institute on Aging | 2023 to 2025 | $1,657,399 | September 22, 2023 | May 31, 2027 | CHENG, FEIXIONG | reporter.nih.gov |
| Gut Microbiota and Cerebral Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,654,119 | August 1, 2020 | July 31, 2025 | ZHU, WEIFEI | reporter.nih.gov |
| Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,616,998 | September 14, 2022 | June 30, 2027 | NI, YING | reporter.nih.gov |
| Defining a pathway for mitochondrial heme trafficking | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,610,870 | September 1, 2023 | August 31, 2027 | STUEHR, DENNIS J | reporter.nih.gov |
| Role of the TLR4 signaling in smooth muscle cell phenotypic transition | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,610,000 | August 1, 2021 | July 31, 2026 | CHEREPANOVA, OLGA | reporter.nih.gov |
| Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $1,610,000 | May 15, 2020 | March 31, 2026 | PEREZ, DIANNE M | reporter.nih.gov |
| Profibrotic Mechanisms of the TRPV4-PI3K-gamma Protein Complex | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,610,000 | August 1, 2021 | December 31, 2025 | OLMAN, MITCHELL ALAN | reporter.nih.gov |
| Molecular Mechanisms of TULP1-Mediated Photoreceptor Degeneration | NIH | National Eye Institute | 2022 to 2025 | $1,610,000 | May 1, 2022 | April 30, 2027 | HAGSTROM, STEPHANIE A | reporter.nih.gov |
| Mechanisms of retinal degeneration in neuroinflammatory demyelinating diseases | NIH | National Eye Institute | 2021 to 2024 | $1,597,925 | January 1, 2021 | November 30, 2025 | DESILVA, TARA MARIA | reporter.nih.gov |
| New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis | NIH | National Eye Institute | 2021 to 2024 | $1,597,925 | May 1, 2021 | April 30, 2026 | LIN, FENG C | reporter.nih.gov |
| Multi-organ protection from hyperoxia of the severely premature infant | NIH | National Eye Institute | 2021 to 2025 | $1,597,925 | August 1, 2015 | May 31, 2029 | SEARS, JONATHAN E | reporter.nih.gov |
| Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,597,925 | August 1, 2022 | July 31, 2027 | BAO, SHIDENG | reporter.nih.gov |
| A novel determinant of prostate cancer growth | NIH | National Cancer Institute | 2021 to 2025 | $1,596,877 | April 1, 2021 | March 31, 2026 | HEEMERS, HANNELORE | reporter.nih.gov |
| Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy | NIH | National Eye Institute | 2022 to 2025 | $1,593,267 | July 1, 2022 | June 30, 2027 | RANDLEMAN, JAMES BRADLEY | reporter.nih.gov |
| Novel unconventional myosins in B cell homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,587,906 | June 1, 2023 | May 31, 2028 | GUPTA, NEETU | reporter.nih.gov |
| Innate immune responses to tissue infection by intestinal fungi inhibit wound repair | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,580,412 | November 14, 2023 | October 31, 2028 | STAPPENBECK, THADDEUS S | reporter.nih.gov |
| Gut microbial dietary phenylalanine metabolism and heart failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,580,134 | January 5, 2024 | December 31, 2027 | HAZEN, STANLEY L | reporter.nih.gov |
| Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,574,001 | July 1, 2021 | June 30, 2026 | SMITH, JONATHAN D | reporter.nih.gov |
| Comparison of cervical intraepithelial neoplasia 2/3 treatment outcomes with a portable LMIC-adapted thermal ablation device vs. gas-based cryotherapy | NIH | National Cancer Institute | 2021 to 2023 | $1,573,574 | January 12, 2018 | June 30, 2025 | CREMER, MIRIAM | reporter.nih.gov |
| Machine and deep learning for finding multimodal imaging biomarkers in prodromal AD | NIH | National Institute on Aging | 2024 to 2025 | $1,573,529 | April 1, 2021 | March 31, 2027 | CORDES, DIETMAR | reporter.nih.gov |
| Nutrition, terminal NAD metabolites and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,568,658 | June 1, 2024 | April 30, 2028 | HAZEN, STANLEY L | reporter.nih.gov |
| Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD) | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $1,561,381 | June 1, 2021 | May 31, 2026 | SHALLCROSS, AMANDA J | reporter.nih.gov |
| Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD)- Cleveland Clinic Clinical Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,561,055 | August 1, 2018 | June 30, 2029 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,557,093 | September 20, 2023 | September 30, 2025 | SAYEGH, RONY ROGER | reporter.nih.gov |
| Creeping fat and Crohn's disease associated strictures | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,556,335 | July 15, 2020 | March 31, 2026 | RIEDER, FLORIAN | reporter.nih.gov |
| Novel oxidative pathway targets microglia in Alzheimer's disease | NIH | National Institute on Aging | 2024 to 2025 | $1,550,345 | August 15, 2024 | May 31, 2029 | BYZOVA, TATIANA V | reporter.nih.gov |
| Imaging Assessments of ARPKD Kidney Disease Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,546,644 | August 20, 2019 | February 28, 2029 | DELL, KATHERINE MACRAE | reporter.nih.gov |
| Hydrogen sulfide functions as a tumor suppressor in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,529,987 | April 1, 2023 | February 29, 2028 | HINE, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Role of CDCP1 in the pathogenesis of autoimmune uveitis | NIH | National Eye Institute | 2023 to 2025 | $1,512,033 | July 1, 2023 | June 30, 2028 | LIN, FENG C | reporter.nih.gov |
| Regulation of B cells in the CNS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,502,050 | September 15, 2013 | March 31, 2026 | BERGMANN, CORNELIA | reporter.nih.gov |
| Molecular Genetic Dissection of Fenestrated Vascular Development in the Choroid Plexus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,502,050 | September 1, 2020 | June 30, 2026 | MATSUOKA, RYOTA | reporter.nih.gov |
| Cleveland Kidney, Urology and Hematology Training Network | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,480,500 | September 15, 2021 | May 31, 2027 | SEDOR, JOHN R. | reporter.nih.gov |
| Supporting Multidisciplinary Achievement in Respiratory Research Training (SMARRT) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,456,129 | July 1, 2021 | June 30, 2027 | DWEIK, RAED A. | reporter.nih.gov |
| Live-Cell Chromatin Imaging and Biology: Application to Extrachromosomal DNA | NIH | National Institute of General Medical Sciences | 2023 | $1,449,000 | September 1, 2023 | August 31, 2026 | XIE, LIANGQI | reporter.nih.gov |
| ApoA1 lipidation by ABCA1 in HDL biogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,438,368 | April 1, 2016 | June 30, 2025 | SMITH, JONATHAN D | reporter.nih.gov |
| Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,438,273 | August 1, 2019 | April 30, 2025 | DAVALOS, DIMITRIOS | reporter.nih.gov |
| Targeting oncogenic dopamine receptor signaling in glioblastoma | NIH | National Cancer Institute | 2021 to 2023 | $1,424,613 | December 6, 2018 | November 30, 2024 | LEE, JEONGWU | reporter.nih.gov |
| KSHVmediated regulation of proline metabolism | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,404,235 | September 23, 2020 | November 30, 2024 | JUNG, JAE U | reporter.nih.gov |
| Forward genetic analysis of biliary system formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,402,632 | July 25, 2015 | April 30, 2027 | SAKAGUCHI, TAKUYA | reporter.nih.gov |
| Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF | NIH | National Cancer Institute | 2021 to 2024 | $1,383,201 | June 19, 2014 | December 31, 2024 | HEEMERS, HANNELORE | reporter.nih.gov |
| KSHV-mediated metabolic reprogramming for LANA expression and viral persistency | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,350,832 | June 14, 2024 | April 30, 2029 | JUNG, JAE U | reporter.nih.gov |
| Mechanisms of Airway Epithelial Barrier Dysfunction by Respiratory Syncytial Virus and Environmental Stimuli | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,319,730 | July 1, 2019 | June 30, 2025 | REZAEE, FARIBA | reporter.nih.gov |
| Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes - (ARMMS-T2D) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $1,308,257 | July 4, 2017 | June 30, 2025 | KIRWAN, JOHN P. | reporter.nih.gov |
| Nitric oxide induced soluble guanylate cyclase dysfunction or activation: Implications as a disease indicator or in therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,284,685 | September 15, 2023 | June 30, 2025 | GHOSH, ARNAB | reporter.nih.gov |
| Role of TLR2 in angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,282,712 | February 1, 2019 | January 31, 2025 | BYZOVA, TATIANA V | reporter.nih.gov |
| Calcium imaging-based insights and guidance of deep brain stimulation to enhance chronic, post-stroke rehabilitation in a rodent model of ischemia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,268,198 | August 1, 2024 | July 31, 2029 | DANA, HOD MICHAEL | reporter.nih.gov |
| The I-SCORE (Intensive Stroke Cycling for Optimal Recovery and Economic value) Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,262,929 | April 1, 2024 | February 28, 2029 | LINDER, SUSAN MARIE | reporter.nih.gov |
| 7/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,262,779 | September 25, 2017 | May 31, 2028 | POGGIO, EMILIO DANIEL | reporter.nih.gov |
| Interplay between LINE-1 retrotransposons, condensins, and IFN | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,232,851 | June 1, 2023 | February 28, 2027 | LONGWORTH, MICHELLE S | reporter.nih.gov |
| tPA nanoconjugate for stroke therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,227,994 | September 30, 2019 | July 31, 2025 | LABHASETWAR, VINOD D | reporter.nih.gov |
| The Interplay between Genetics and Aerobic Exercise to Slow Parkinson's disease (GEARS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,210,130 | January 18, 2024 | December 31, 2028 | ALBERTS, JAY L. | reporter.nih.gov |
| The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,207,500 | March 1, 2020 | February 28, 2025 | LIU, CAINI | reporter.nih.gov |
| The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,207,500 | September 14, 2021 | August 31, 2025 | FOX, PAUL L | reporter.nih.gov |
| Immune Function in Sepsis: Role of Sirtuin | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,207,500 | May 1, 2023 | February 29, 2028 | VACHHARAJANI, VIDULA | reporter.nih.gov |
| Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging | NIH | National Institute on Aging | 2021 | $1,205,802 | September 5, 2021 | August 31, 2023 | CHENG, FEIXIONG | reporter.nih.gov |
| Sema3C Signaling as an Alternative Activator of Canonical Wnt Signaling in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,195,425 | April 1, 2023 | March 31, 2028 | YU, JENNIFER S | reporter.nih.gov |
| Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,164,262 | September 15, 2018 | November 30, 2023 | SAAB, CARL Y | reporter.nih.gov |
| Molecular Profiling and Biomarkers of Memory Phenotypes in Temporal Lobe Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,155,956 | July 15, 2024 | June 30, 2029 | BUSCH, ROBYN M | reporter.nih.gov |
| The vital role of T403 phosphorylation of STAT2 in post-viral bacterial pneumonia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,127,000 | March 20, 2024 | February 28, 2029 | WANG, YUXIN | reporter.nih.gov |
| Development of a first-in-class complement inhibitor for treating complement-mediated hematologic diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,127,000 | September 5, 2024 | July 31, 2026 | LIN, FENG C | reporter.nih.gov |
| Small Molecule Therapeutic for Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,118,301 | December 15, 2023 | November 30, 2025 | PRASAD, SATHYAMANGLA V | reporter.nih.gov |
| Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,102,741 | September 20, 2020 | August 31, 2025 | HAOUZI, PHILIPPE A | reporter.nih.gov |
| Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma | NIH | National Cancer Institute | 2023 to 2025 | $1,086,450 | December 1, 2022 | November 30, 2027 | BAO, SHIDENG | reporter.nih.gov |
| T cell-dependent regulation of microglia demyelinating functions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,056,564 | March 1, 2019 | January 31, 2025 | BERGMANN, CORNELIA | reporter.nih.gov |
| Endocytic Trafficking of ADCs in GBM cancer stem-like cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,051,314 | April 1, 2019 | March 31, 2024 | GLADSON, CANDECE L | reporter.nih.gov |
| Targeting TNFR2 Pathways in Psoriatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,048,432 | July 8, 2019 | December 31, 2024 | HUSNI, ELAINE | reporter.nih.gov |
| Studying alcohol-associated liver disease and its interaction with rs738409 variant in PNPLA3 in a liver culture model | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $1,046,954 | September 25, 2024 | June 30, 2029 | WU, XIANFANG | reporter.nih.gov |
| Per-Oral Pyloromyotomy (POP) in the treatment of medical refractory gastroparesis : A randomized, sham-controlled trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,044,209 | July 15, 2020 | March 31, 2026 | ALLEMANG, MATTHEW THOMAS | reporter.nih.gov |
| Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxide | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,042,456 | September 1, 2019 | June 30, 2024 | STUEHR, DENNIS J | reporter.nih.gov |
| Developing hemophilia A therapeutics by targeting translational and posttranslational regulation of FVIII | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,036,148 | March 15, 2024 | January 31, 2028 | ZHANG, BIN | reporter.nih.gov |
| Vista, A Novel Checkpoint that Suppresses Anti-Tumor T Cell Responses | NIH | National Cancer Institute | 2021 to 2023 | $1,028,770 | September 1, 2012 | December 31, 2024 | WANG, LI LILY | reporter.nih.gov |
| Activation of the beta-3 integrins: Role of the Kindlins | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,023,294 | July 1, 2009 | March 31, 2023 | PLOW, EDWARD FRANKLIN | reporter.nih.gov |
| Stimulating Retina Regeneration from Muller Cells in Progressive Retinal Degenerations | NIH | National Eye Institute | 2021 to 2022 | $1,020,271 | May 1, 2020 | March 31, 2024 | PERKINS, BRIAN D | reporter.nih.gov |
| Actin methylation as a novel mechanism that regulates gut barrier integrity and repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,011,436 | January 15, 2024 | December 31, 2028 | IVANOV, ANDREI IVANOVICH | reporter.nih.gov |
| The effect of nucleosomes on the earliest stages of RNA polymerase II transcription | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $969,326 | September 1, 2018 | May 31, 2028 | LUSE, DONAL | reporter.nih.gov |
| Functional consequences of mutations in spliceosomal small nuclear RNAs | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $968,639 | August 1, 2019 | July 31, 2024 | PADGETT, RICHARD A | reporter.nih.gov |
| Epithelial cytokeratins control corneal inflammation through intrinsic mechanisms | NIH | National Eye Institute | 2021 to 2022 | $967,876 | September 1, 2019 | June 30, 2024 | TAM, K. P. CONNIE | reporter.nih.gov |
| Cerebellar deep brain stimulation to enhance chronic post-stroke rehabilitation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $958,678 | March 1, 2018 | February 29, 2024 | BAKER, KENNETH B | reporter.nih.gov |
| Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $956,383 | September 1, 2020 | September 30, 2022 | MISHRA, VIRENDRA R | reporter.nih.gov |
| The UroMonitor: Innovative Technology to Improve Management of Bladder Dysfunction | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $948,822 | September 1, 2021 | August 31, 2024 | DAMASER, MARGOT S. | reporter.nih.gov |
| Complement in Paclitaxel-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 to 2024 | $936,532 | March 5, 2020 | February 28, 2026 | XU, JIJUN | reporter.nih.gov |
| Deciphering the Roles of STING-Mediated T cell Pyroptosis in Antitumor Immunity | NIH | National Cancer Institute | 2024 to 2025 | $935,004 | July 1, 2024 | June 30, 2029 | WU, JIANJUN | reporter.nih.gov |
| Multisite phosphorylated S6K1 directs a regulatory module determining adipocyte lipid metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $934,980 | April 9, 2020 | January 31, 2024 | FOX, PAUL L | reporter.nih.gov |
| Mechanisms of Vision Loss in X-Linked Juvenile Retinoschisis | NIH | National Eye Institute | 2021 to 2022 | $933,720 | March 1, 2019 | February 29, 2024 | PEACHEY, NEAL S. | reporter.nih.gov |
| Role of sulfide in oral microbiota-host interactions that promote periodontitis | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $908,000 | December 1, 2022 | November 30, 2025 | STACY, APOLLO | reporter.nih.gov |
| Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $905,274 | September 15, 2020 | July 31, 2024 | IVANOV, ANDREI IVANOVICH | reporter.nih.gov |
| Mechanisms of HIF1 alpha mediated dysregulated skeletal muscle proteostasis in alcoholic liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $895,645 | March 1, 2021 | February 28, 2027 | WELCH, NICOLE | reporter.nih.gov |
| Specific-sized hyaluronan: a dual targeted therapy for ALD | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $880,703 | August 1, 2018 | July 31, 2025 | NAGY, LAURA E. | reporter.nih.gov |
| 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2025 | $873,890 | September 1, 2024 | August 31, 2030 | HERESI DAVILA, GUSTAVO ADOLFO | reporter.nih.gov |
| CDK6-dependent metabolic reprogramming in KSHV pathogenesis | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $870,741 | September 1, 2024 | May 31, 2029 | ZHAO, JUN | reporter.nih.gov |
| Deciphering MDSC function for GBM targeting | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $869,874 | April 1, 2019 | March 31, 2025 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Mechanistic basis of exercise responses in liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $862,548 | September 1, 2023 | July 31, 2027 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC) | NIH | National Cancer Institute | 2021 to 2022 | $842,361 | December 27, 2016 | November 30, 2022 | MAYTIN, EDWARD V | reporter.nih.gov |
| Supporting pregnant patients as they face a changing landscape of prenatal genetic tests and post-diagnosis options | NIH | National Human Genome Research Institute | 2024 | $831,046 | September 18, 2024 | August 31, 2025 | FARRELL, RUTH | reporter.nih.gov |
| Assay Development for Discovery of a Small Molecule Inhibitor of a Novel Metabolic Pathway that Drives Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $805,000 | March 1, 2020 | December 31, 2023 | FOX, PAUL L | reporter.nih.gov |
| ER-to-Golgi transport of coagulation factors V and VIII | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $805,000 | December 26, 2008 | June 30, 2024 | ZHANG, BIN | reporter.nih.gov |
| Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors | NIH | National Institute of Mental Health | 2023 to 2024 | $805,000 | September 1, 2023 | December 15, 2024 | LOUVEAU, ANTOINE | reporter.nih.gov |
| Molecular mechanism of Zika virus-induced premature craniofacial suture closure | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $805,000 | January 1, 2024 | December 31, 2028 | CHEN, WEIQIANG | reporter.nih.gov |
| Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer | NIH | National Cancer Institute | 2021 to 2023 | $802,660 | December 1, 2019 | June 9, 2023 | SHARIFI, NIMA | reporter.nih.gov |
| A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimer’s Disease and Longevity | NIH | National Institute on Aging | 2025 | $802,034 | June 1, 2025 | February 28, 2030 | CHENG, FEIXIONG | reporter.nih.gov |
| Artificial sweeteners and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $796,395 | March 4, 2025 | December 31, 2028 | HAZEN, STANLEY L | reporter.nih.gov |
| Targeting macrophage reprogramming in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $793,965 | September 1, 2023 | August 31, 2028 | CHEN, PEIWEN | reporter.nih.gov |
| Mechanism and therapeutic potential of microglia regulation in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $792,925 | September 1, 2022 | July 31, 2027 | CHEN, PEIWEN | reporter.nih.gov |
| Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end | NIH | National Cancer Institute | 2021 to 2022 | $790,332 | February 1, 2019 | December 30, 2022 | TING, ANGELA H | reporter.nih.gov |
| Demonstrating the Feasibility of Democratized Push-Button Autonomous Cardiac MRI exam in Community Family Health Centers (AutoCMR for FHC) | NIH | National Heart, Lung, and Blood Institute | 2025 | $783,801 | September 3, 2025 | May 31, 2029 | NGUYEN, CHRISTOPHER T | reporter.nih.gov |
| The Role of Bacterial Choline Metabolism in Host Stress Responses | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $783,358 | June 1, 2019 | March 31, 2024 | BROWN, JONATHAN MARK | reporter.nih.gov |
| A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis | NIH | National Eye Institute | 2021 to 2022 | $780,850 | April 1, 2019 | March 31, 2024 | LIN, FENG C | reporter.nih.gov |
| Broad Bandwidth Transducers for High Resolution Information Rich IVUS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $760,655 | June 10, 2022 | April 30, 2024 | FLEISCHMAN, AARON J | reporter.nih.gov |
| Elucidating a novel molecular biomarker for castration-resistant prostate cancer | NIH | National Cancer Institute | 2021 to 2022 | $757,103 | April 1, 2018 | March 31, 2023 | SHARIFI, NIMA | reporter.nih.gov |
| Targeting ZDHHC13-activated palmitoylation for melanoma treatment | NIH | National Cancer Institute | 2021 to 2023 | $746,997 | July 1, 2019 | June 30, 2024 | CHEN, SHUYANG | reporter.nih.gov |
| Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2024 | $746,997 | May 1, 2022 | April 30, 2025 | CHEN, WEIQIANG | reporter.nih.gov |
| Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes | NIH | National Cancer Institute | 2022 to 2024 | $746,997 | July 3, 2019 | July 31, 2025 | MCGRAIL, DANIEL JAMES | reporter.nih.gov |
| ASC oligomerization and transmission as an initiating event for protein aggregation in Synucleinopathy Dementias | NIH | National Institute on Aging | 2022 to 2024 | $746,997 | September 1, 2022 | August 31, 2025 | PANICKER, NIKHIL | reporter.nih.gov |
| Developing next generation multiphoton systems to reveal cortico-thalamic interactions underlying short-term memory in behaving mice | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2024 | $746,997 | September 1, 2022 | May 31, 2025 | YILDIRIM, MURAT | reporter.nih.gov |
| Deamidation-mediated metabolic reprogramming by KSHV in cell proliferation and tumorigenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $746,646 | July 1, 2021 | June 30, 2025 | ZHAO, JUN | reporter.nih.gov |
| Development of a Miniaturized, Pediatric Continuous-Flow Total Artificial Heart with a Single Moving Part | NIH | National Heart, Lung, and Blood Institute | 2021 | $746,410 | April 1, 2018 | February 28, 2023 | FUKAMACHI, KIYOTAKA | reporter.nih.gov |
| Master - 2/2 Empaglifozin To Improve Right Ventricular Function in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $746,327 | September 1, 2024 | August 31, 2030 | GASSMAN, JENNIFER J | reporter.nih.gov |
| The role of PDK4 in alcohol-associated liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $744,213 | September 22, 2021 | August 31, 2026 | WU, JIANGUO | reporter.nih.gov |
| Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $743,302 | May 1, 2025 | February 28, 2029 | BROWN, JONATHAN MARK | reporter.nih.gov |
| Mitochondrial Mechanisms in Asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $732,225 | August 1, 2025 | April 30, 2030 | ERZURUM, SERPIL C. | reporter.nih.gov |
| Repurposing Siponimod for Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $731,856 | August 15, 2021 | October 15, 2021 | SABBAGH, MARWAN NOEL | reporter.nih.gov |
| A Nomogram to Predict Seizure Outcomes after Resective Epilepsy Surgery | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $728,061 | May 15, 2017 | April 30, 2023 | JEHI, LARA | reporter.nih.gov |
| Homologous recombination repair pathway mutations and genetic mechanisms shaping anti-tumor immunity and immunotherapy efficacy | NIH | National Cancer Institute | 2025 | $713,601 | August 1, 2025 | July 31, 2030 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Personalized vasopressor therapy in patients with septic shock | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $708,473 | September 1, 2022 | August 31, 2027 | BAUER, SETH | reporter.nih.gov |
| Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $703,753 | September 22, 2006 | September 15, 2024 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $701,158 | June 22, 2023 | May 31, 2026 | COREY, SETH JOEL | reporter.nih.gov |
| Matrix Regenerative Nanotherapeutic Platform for Pelvic Organ Prolapse | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $688,436 | September 1, 2025 | August 31, 2030 | DAMASER, MARGOT S. | reporter.nih.gov |
| Impact of early-life pathogen exposures on pre-erythrocytic malaria vaccine effectiveness in Kenyan infants | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $682,200 | August 22, 2025 | July 31, 2030 | DOBBS, KATHERINE ROSE | reporter.nih.gov |
| Novel Cardiac MRI-Based Predictors for Tetralogy of Fallot: Deformation, Kinematic, and Geometric Analyses | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $677,485 | February 15, 2021 | January 31, 2027 | TANDON, ANIMESH | reporter.nih.gov |
| Modeling Transition Metal Ion Binding to Proteins | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $674,546 | September 1, 2019 | July 31, 2028 | MERZ, KENNETH M. | reporter.nih.gov |
| Parent-Mediated Teleheath Intervention for Insomnia in Young Autistic Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $668,178 | September 1, 2025 | August 31, 2030 | JOHNSON, CYNTHIA R | reporter.nih.gov |
| Neural Mechanisms underlying the benefits of Aerobic Exercise in Advanced Parkinson's disease | NIH | National Institute on Aging | 2025 | $665,118 | September 15, 2025 | August 31, 2030 | ALBERTS, JAY L. | reporter.nih.gov |
| Platelets in Cancer | NIH | National Heart, Lung, and Blood Institute | 2021 | $663,334 | July 15, 2018 | June 30, 2024 | BYZOVA, TATIANA V | reporter.nih.gov |
| Translational science specialist in genitourinary cancers | NIH | National Cancer Institute | 2021 to 2024 | $662,140 | August 13, 2020 | July 31, 2025 | BERK, MICHAEL P. | reporter.nih.gov |
| The role of HMGB1 in the lung response to bacterial injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $656,988 | August 1, 2025 | April 30, 2030 | MESSER, JEANNETTE SOPHIA | reporter.nih.gov |
| Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2025 | $654,837 | September 22, 2025 | June 30, 2030 | WANG, LI LILY | reporter.nih.gov |
| Modulation of Protective RAS-GPCR Pathways in Aortic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $647,156 | May 1, 2018 | April 30, 2024 | KARNIK, SADASHIVA S | reporter.nih.gov |
| Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $641,557 | September 22, 2018 | December 31, 2024 | NAGY, LAURA E. | reporter.nih.gov |
| MR Fingerprinting for Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $639,800 | January 15, 2019 | March 31, 2030 | WANG, ZHONG IRENE | reporter.nih.gov |
| Assessment of lenalidomide to treat Alzheimer's disease | NIH | National Institute on Aging | 2021 | $639,729 | September 1, 2018 | October 15, 2021 | SABBAGH, MARWAN NOEL | reporter.nih.gov |
| Mitochondria in cardiomyocyte-fibroblast transcellular cross-talk | NIH | National Heart, Lung, and Blood Institute | 2025 | $639,621 | May 15, 2025 | March 31, 2029 | PRASAD, SATHYAMANGLA V | reporter.nih.gov |
| Role of SMARCA5 in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $638,697 | July 15, 2025 | June 30, 2030 | YU, JENNIFER S | reporter.nih.gov |
| Improving sarcoidosis patients’ care with a collaboratively developed, patient centered program | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $638,620 | July 15, 2022 | March 31, 2027 | HARPER, LOGAN | reporter.nih.gov |
| Pain avoidance behavior and its relation to risk for opioid use in chronic pain patients | NIH | National Institute on Drug Abuse | 2021 to 2024 | $629,848 | August 15, 2020 | July 31, 2025 | GOPALAKRISHNAN, RAGHAVAN | reporter.nih.gov |
| A SkeleTal muscle Recovery Intervention with Dietary protein in Heart Failure (ASTRID-HF) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $626,725 | March 15, 2023 | January 31, 2027 | VEST, AMANDA RUTH | reporter.nih.gov |
| Improving colorectal cancer screening decisions through consideration of life expectancy | NIH | National Institute on Aging | 2025 | $625,452 | January 1, 2025 | December 31, 2029 | MARTINEZ, KATHRYN ANNE | reporter.nih.gov |
| Remodeling host immunity in oral cancer with personalized RNA nanoparticle vaccines | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $621,216 | January 12, 2022 | June 30, 2025 | SILVER, NATALIE LEA | reporter.nih.gov |
| Novel role of integrins in paracrine regulation of vasculature | NIH | National Heart, Lung, and Blood Institute | 2021 | $617,218 | July 14, 2003 | June 30, 2024 | BYZOVA, TATIANA V | reporter.nih.gov |
| A Cognitive Risk Calculator and Screening tool for Primary Care Settings | NIH | National Institute on Aging | 2021 | $615,414 | September 30, 2020 | August 31, 2022 | FLODEN, DARLENE | reporter.nih.gov |
| Protective factors in diabetic kidney disease in patients with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $606,740 | January 1, 2023 | December 31, 2025 | CARAMORI, MARIA LUIZA A | reporter.nih.gov |
| Integrin regulation of vascular function in Alzheimer's disease | NIH | National Institute on Aging | 2023 | $605,489 | September 1, 2023 | August 31, 2025 | LOUVEAU, ANTOINE | reporter.nih.gov |
| Alcohol and gut-brain axis and the role of butyrate on neuroinflammation and pain sensitivity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $601,129 | September 25, 2025 | June 30, 2030 | CRESCI, GAIL ANN | reporter.nih.gov |
| Developing a Donor-Candidate Risk Prediction System to Optimize Lung Allocation and Transplant Outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $598,206 | April 1, 2022 | March 31, 2027 | LEHR, CARLI JESSICA | reporter.nih.gov |
| Sarcopenia in cirrhosis is mediated by a hyperammonemic stress response | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $579,497 | August 1, 2018 | April 30, 2025 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Role of melanopsin in outer segment renewal | NIH | National Eye Institute | 2025 | $574,158 | September 1, 2025 | April 30, 2030 | RAO, SUJATA | reporter.nih.gov |
| Assessing feasibility of gastric cancer screening in the US | NIH | National Cancer Institute | 2025 | $564,414 | April 1, 2025 | March 31, 2030 | KIM, MICHELLE KANG | reporter.nih.gov |
| Neural Coding and Control of Pain Detection in Somatosensory Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $560,934 | April 1, 2025 | March 31, 2030 | SAAB, CARL Y | reporter.nih.gov |
| Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity | NIH | National Institute on Aging | 2025 | $552,045 | August 15, 2023 | August 31, 2028 | CHENG, FEIXIONG | reporter.nih.gov |
| Automated Arthroscopic Partial Meniscectomy Patient Outcome Prediction using Deep Learning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $544,570 | July 1, 2022 | June 30, 2027 | YANG, MINGRUI | reporter.nih.gov |
| Improving Adherence with Statins Through Use of the Statin Choice Decision Aid | NIH | National Heart, Lung, and Blood Institute | 2022 | $535,354 | September 19, 2022 | February 29, 2024 | MARTINEZ, KATHRYN ANNE | reporter.nih.gov |
| Host Regulation of Flavivirus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $530,385 | June 6, 2025 | May 31, 2030 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Quadrupole Time-of-Flight LC-MS | NIH | Office of the Director, National Institutes of Health | 2021 | $529,999 | April 15, 2021 | April 14, 2022 | WILLARD, BELINDA BELLE | reporter.nih.gov |
| Impact of Disparities Affecting Survival among Advanced Heart Failure Patients and Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 | $526,607 | April 1, 2018 | January 31, 2023 | HSICH, EILEEN MICHELLE | reporter.nih.gov |
| Alcoholic Hepatitis Consortia: an intramural/extramural collaboration to unravel genetic determinants | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $509,026 | September 20, 2017 | August 31, 2023 | NAGY, LAURA E. | reporter.nih.gov |
| Deep cerebellar electrical stimulation for post-stroke motor recovery | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $507,787 | September 30, 2016 | June 30, 2023 | MACHADO, ANDRE GUELMAN | reporter.nih.gov |
| Effect of Lipids on Vascular Graft Healing | NIH | National Heart, Lung, and Blood Institute | 2021 | $503,544 | August 1, 2000 | November 30, 2022 | GRAHAM, LINDA M | reporter.nih.gov |
| Regulation and Function of Oral Resident Memory T Cells | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $498,000 | September 1, 2023 | August 31, 2025 | STOLLEY, JAMES MICHAEL | reporter.nih.gov |
| Modifiable Determinants of Disparities in Multiple Myeloma Treatment Patterns | NIH | National Cancer Institute | 2024 to 2025 | $497,998 | February 1, 2024 | January 31, 2027 | GASOYAN, HAMLET | reporter.nih.gov |
| Exploring palmitoylation dynamics: impacts on Cadherin-Catenin adhesion and lipid metabolism in the progression of melanoma lung metastasis | NIH | National Cancer Institute | 2025 | $487,468 | September 1, 2025 | August 31, 2030 | CHEN, SHUYANG | reporter.nih.gov |
| Defining role of Long non-coding RNA (LncRNA) Gm15417 in iNKT development and subset differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $486,732 | May 2, 2022 | April 30, 2025 | BASU, JAYATI | reporter.nih.gov |
| Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer | NIH | National Cancer Institute | 2021 to 2022 | $486,410 | March 1, 2019 | January 16, 2023 | LEE, BYRON H | reporter.nih.gov |
| Personalizing Preoperative Stress Testing Using Machine Learning | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $483,141 | January 15, 2019 | June 30, 2024 | PAPPAS, MATTHEW | reporter.nih.gov |
| Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity | NIH | National Institute on Aging | 2023 | $482,520 | August 15, 2023 | August 14, 2025 | CHENG, FEIXIONG | reporter.nih.gov |
| Endogenous synthesis of TRAIL by glioma cancer stem cells and resistance to TRAIL therapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $478,001 | September 18, 2023 | August 31, 2025 | GLADSON, CANDECE L | reporter.nih.gov |
| Quantitative Susceptibility Mapping of Brain Iron in People with HIV: Mechanistic Links to Neuropsychiatric Disorders | NIH | National Institute of Mental Health | 2023 to 2024 | $475,489 | August 1, 2023 | May 31, 2026 | KALLIANPUR, ASHA R | reporter.nih.gov |
| Integrative analysis of proteomics and transcriptomics to delineate vesicular transport related protein abnormalities related to Alzheimer's, Lewy body and mixed Pathologies | NIH | National Institute on Aging | 2022 | $455,583 | June 1, 2022 | May 31, 2025 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Identifying the patient, disease, surgical, and implant positional shift factors that predict outcomes following total shoulder arthroplasty | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $443,449 | April 1, 2020 | March 31, 2024 | RICCHETTI, ERIC T. | reporter.nih.gov |
| Antiviral role of Condensin II | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $442,750 | March 4, 2021 | February 29, 2024 | LONGWORTH, MICHELLE S | reporter.nih.gov |
| Integrin mediated regulation of lymphatics during aging and neurodegeneration | NIH | National Institute on Aging | 2022 | $442,750 | May 15, 2022 | April 30, 2024 | LOUVEAU, ANTOINE | reporter.nih.gov |
| Molecular correlates of sub-regional thalamic degeneration in multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $442,750 | February 1, 2022 | January 31, 2025 | DUTTA, RANJAN | reporter.nih.gov |
| The impact of exercise on subthalamic nucleus neural activity in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $442,750 | August 15, 2022 | July 31, 2025 | ALBERTS, JAY L. | reporter.nih.gov |
| Targeting and Stimulating Cortical Area 3a to Restore Proprioception | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $442,750 | May 15, 2023 | April 30, 2026 | TAYLOR, DAWN MARIE | reporter.nih.gov |
| Investigation of discrete neurodegenerative changes of the in vivo multiple sclerosis spinal cord using 7T MRI | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $442,750 | July 18, 2024 | June 30, 2026 | MAHAJAN, KEDAR | reporter.nih.gov |
| Role of nitrate in microbiota ecology | NIH | National Institute of General Medical Sciences | 2025 | $442,750 | August 15, 2025 | April 30, 2030 | STACY, APOLLO | reporter.nih.gov |
| Induce and Image extrachromosomal DNA in human glioblastoma avatar | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $442,750 | August 1, 2025 | July 31, 2027 | XIE, LIANGQI | reporter.nih.gov |
| Systematic identification of drivers controlling Fusobacterium and oral squamous cell carcinoma interactions | NIH | National Institute of Dental & Craniofacial Research | 2025 | $442,750 | July 1, 2025 | June 30, 2027 | MCGRAIL, DANIEL JAMES | reporter.nih.gov |
| A Pathomimetic Gingiva-on-a-Chip for Assessing Microbiota-Directed Anti-Inflammatory Therapeutics | NIH | National Institute of Dental & Craniofacial Research | 2025 | $442,750 | August 14, 2025 | August 13, 2027 | STACY, APOLLO | reporter.nih.gov |
| Degradomics of proteolytic mechanisms in post-traumatic osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $434,682 | August 22, 2025 | June 30, 2030 | APTE, SUNEEL S | reporter.nih.gov |
| Failure with Continuity and Its Relation to Rotator Cuff Repair Clinical Outcomes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $433,919 | April 1, 2016 | January 31, 2022 | DERWIN, KATHLEEN ANNE | reporter.nih.gov |
| 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 | $433,123 | September 1, 2024 | August 31, 2025 | HERESI DAVILA, GUSTAVO ADOLFO | reporter.nih.gov |
| CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy | NIH | National Cancer Institute | 2022 to 2023 | $432,123 | February 1, 2022 | June 9, 2023 | SHARIFI, NIMA | reporter.nih.gov |
| Molecular Mechanism of Glucocorticoid Receptor, Cytochrome P450, and P-Glycoprotein Axis on Drug Regulation at the Blood-Brain Barrier in Epilepsy with Focal Cortical Dysplasia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $431,676 | December 6, 2024 | November 30, 2029 | GHOSH, CHAITALI | reporter.nih.gov |
| Immunogenomics platform for the analysis of cancer | NIH | National Cancer Institute | 2024 to 2025 | $425,134 | September 13, 2024 | August 31, 2029 | MAKAROV, VLADIMIR | reporter.nih.gov |
| Transcriptional regulation of Myelopoiesis | NIH | National Heart, Lung, and Blood Institute | 2024 | $421,799 | July 15, 2024 | November 30, 2024 | BASU, JAYATI | reporter.nih.gov |
| Cilia Assembly and Transport in Photoreceptor Cells | NIH | National Eye Institute | 2021 | $421,194 | August 1, 2006 | June 30, 2023 | PERKINS, BRIAN D | reporter.nih.gov |
| The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $420,472 | April 8, 2021 | November 30, 2021 | PIZARRO, THERESA TORRES | reporter.nih.gov |
| Gender and Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 | $419,061 | January 1, 2023 | June 27, 2023 | ZEIN, JOE | reporter.nih.gov |
| Elucidating genetics of response to immune checkpoint blockade in lung cancer | NIH | National Cancer Institute | 2021 | $418,751 | January 18, 2017 | December 31, 2022 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Forging a new path with cyclin-dependent kinase inhibitors to treat epithelioid hemangioendothelioma | NIH | National Cancer Institute | 2024 to 2025 | $413,972 | February 1, 2024 | January 31, 2026 | RUBIN, BRIAN P | reporter.nih.gov |
| Targeting NEK2 to potentiate standard of care therapies for breast cancer | NIH | National Cancer Institute | 2024 to 2025 | $413,972 | February 1, 2024 | January 31, 2026 | KERI, RUTH A. | reporter.nih.gov |
| Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function | NIH | National Cancer Institute | 2024 | $413,971 | July 8, 2024 | June 30, 2026 | WANG, LI LILY | reporter.nih.gov |
| Characterization of sarcopenia in heart failure by T1rho magnetic resonance fingerprinting | NIH | National Institute on Aging | 2022 to 2024 | $412,244 | July 15, 2022 | August 2, 2024 | ECK, BRENDAN LEE | reporter.nih.gov |
| Elucidating and Leveraging the mTOR Negative Feedback Pathway in Breast Cancer | NIH | National Cancer Institute | 2021 | $410,801 | August 1, 2017 | July 31, 2023 | KERI, RUTH A. | reporter.nih.gov |
| Hyperthermic Intraperitoneal Chemotherapy Mechanisms in Epithelial Ovarian Cancer | NIH | National Cancer Institute | 2021 to 2022 | $410,209 | June 1, 2021 | May 31, 2023 | REIZES, OFER | reporter.nih.gov |
| The Roles of a Novel Immune-Checkpoint Receptor Complex in Driving T Cell Dysfunction in Cancer | NIH | National Cancer Institute | 2022 to 2023 | $409,455 | February 8, 2022 | January 31, 2024 | WANG, LI LILY | reporter.nih.gov |
| Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer | NIH | National Cancer Institute | 2022 to 2023 | $409,455 | March 1, 2022 | February 28, 2025 | SAUNTHARARAJAH, YOGEN | reporter.nih.gov |
| Cancer-specific metabolites as cues to engineer and target anti-tumor therapeutic bacteria | NIH | National Cancer Institute | 2022 to 2023 | $409,455 | August 1, 2022 | July 31, 2025 | DWIDAR, MOHAMMED | reporter.nih.gov |
| ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $402,500 | September 25, 2017 | August 31, 2023 | SILVERMAN, ROBERT H. | reporter.nih.gov |
| Impact of microfibril turnover on vascular development and disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $402,500 | December 1, 2021 | July 31, 2022 | MEAD, TIMOTHY JOSEPH | reporter.nih.gov |
| The vital role of T404 phosphorylation of STAT2 in post-viral bacterial pneumonia | NIH | National Heart, Lung, and Blood Institute | 2022 | $402,500 | September 1, 2022 | August 31, 2024 | WANG, YUXIN | reporter.nih.gov |
| Synthetic biology tools and strategies to streamline the sensing and responding to disease cues in engineered theragnostic bacteria. | NIH | National Institute of General Medical Sciences | 2025 | $402,500 | January 1, 2025 | November 30, 2029 | DWIDAR, MOHAMMED | reporter.nih.gov |
| The role of protein O-GlcNAcylation in regulating keratinocyte function in skin fibrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $401,433 | September 23, 2023 | August 31, 2025 | WANG, YAN | reporter.nih.gov |
| Microbiome-Mediated Tumor Immunomodulation in a Pathomimetic Colorectal Cancer Chip | NIH | National Cancer Institute | 2025 | $400,890 | March 1, 2025 | February 28, 2028 | KIM, HYUN JUNG | reporter.nih.gov |
| Giving and Taking Away: Mapping Ethical Recommendations for Addressing Emotional Retraumatization in Bionics Research | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $398,466 | September 15, 2025 | September 14, 2027 | MARASCO, PAUL D. | reporter.nih.gov |
| Effector functions and cellular targets of pathogenic plasmacytoid cells in lupus. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $396,250 | December 1, 2016 | November 30, 2022 | JORGENSEN, TRINE NORGAARD | reporter.nih.gov |
| RPE, aging and age-related macular degeneration: the role of oxidative stress | NIH | National Eye Institute | 2021 | $390,425 | September 1, 2017 | May 31, 2022 | BONILHA, VERA L | reporter.nih.gov |
| The proteolytic landscape of osteoarthritic cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $389,620 | April 10, 2022 | March 31, 2025 | APTE, SUNEEL S | reporter.nih.gov |
| Broad Bandwidth Transducers for High Resolution Information Rich IVUS | NIH | National Heart, Lung, and Blood Institute | 2024 | $388,924 | June 10, 2022 | April 30, 2026 | FLEISCHMAN, AARON J | reporter.nih.gov |
| Role of CD6 in the pathogenesis of autoimmune uveitis | NIH | National Eye Institute | 2021 | $384,362 | February 1, 2017 | January 31, 2023 | LIN, FENG C | reporter.nih.gov |
| Variation in Humeral Head Bone Marrow Characteristics and Their Associations with Rotator Cuff Repair Healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $382,212 | September 24, 2021 | August 31, 2023 | DERWIN, KATHLEEN ANNE | reporter.nih.gov |
| Thalamic MRI, histopathologic, and clinical correlations in multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $368,522 | September 15, 2018 | June 30, 2024 | MAHAJAN, KEDAR | reporter.nih.gov |
| Molecular mediators of disparate outcomes experienced by patients of African ancestry with lung cancer | NIH | National Cancer Institute | 2025 | $368,288 | December 4, 2024 | November 30, 2029 | MCGRAIL, DANIEL JAMES | reporter.nih.gov |
| Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: the ACT-BP pilot | NIH | National Heart, Lung, and Blood Institute | 2025 | $362,250 | August 1, 2025 | July 31, 2027 | PFOH, ELIZABETH ROSE | reporter.nih.gov |
| Evaluating Over Constraint of the Patella following MPFL Reconstruction as a Contributing Factor to Progressive Cartilage Degradation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $356,213 | August 1, 2024 | May 31, 2028 | ELIAS, JOHN J | reporter.nih.gov |
| Cytochrome P450-mediated drug interactions at the human blood-brain barrier | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $345,183 | April 1, 2017 | December 31, 2023 | GHOSH, CHAITALI | reporter.nih.gov |
| Leukotriene B4 and IL-8 in alpha-1 heterozygotes (PI*MZ genotype) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $341,121 | April 1, 2024 | March 31, 2029 | TEJWANI, VICKRAM | reporter.nih.gov |
| Role of MLKL in Alcohol-associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $340,656 | September 22, 2021 | August 31, 2023 | WU, XIAOQIN | reporter.nih.gov |
| The impact of antinuclear antibodies on alloimmune responses to renal transplants | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $332,690 | August 1, 2025 | July 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Consequences of gain-of-function RPA1 mutations on telomere function and hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $329,056 | September 15, 2022 | September 14, 2027 | SHARMA, RICHA | reporter.nih.gov |
| Improving Access to Lung Transplant Through Broader Geographic Sharing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $322,748 | August 1, 2018 | July 31, 2024 | TSUANG, WAYNE M | reporter.nih.gov |
| Developing a clinical and research framework for evaluating inflammation pathway dysregulation in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2022 | $322,000 | January 15, 2021 | December 31, 2023 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Integrative analysis of multi-omics data to delineate CCL2 associated inflammatory pathways in Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2022 | $322,000 | March 15, 2021 | February 29, 2024 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Iron Catalyzed H2S and its Prevalence in Hemolytic and Iron Overload Disorders | NIH | National Heart, Lung, and Blood Institute | 2021 | $322,000 | July 1, 2019 | June 30, 2024 | HINE, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Cleveland Precision Medicine Chronic Kidney Disease Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $300,000 | September 15, 2017 | June 30, 2022 | O'TOOLE, JOHN F. | reporter.nih.gov |
| Effect of RCR healing on degenerative shoulder changes and 5y clinical outcomes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $293,811 | September 19, 2024 | August 31, 2025 | DERWIN, KATHLEEN ANNE | reporter.nih.gov |
| PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells | NIH | National Cancer Institute | 2021 to 2022 | $279,799 | December 14, 2020 | March 4, 2022 | CHEON, HYEONJOO | reporter.nih.gov |
| Improving Outcomes in Atrial Fibrillation Through Patient-Centered Decision Making | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $278,478 | May 1, 2018 | April 30, 2023 | MARTINEZ, KATHRYN ANNE | reporter.nih.gov |
| Elucidating the mechanisms of intrinsic stem cell resistance to virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $275,998 | September 2, 2019 | August 5, 2022 | WU, XIANFANG | reporter.nih.gov |
| Conscious ambulatory bladder monitoring to understand neural control of lower urinary tract function | NIH | Office of the Director, National Institutes of Health | 2021 | $274,919 | February 1, 2017 | November 30, 2023 | DAMASER, MARGOT S. | reporter.nih.gov |
| Cole Eye Institute Vision Science Training Program | NIH | National Eye Institute | 2021 to 2025 | $274,512 | April 1, 2015 | March 31, 2026 | ANAND-APTE, BELA | reporter.nih.gov |
| Use of gold-based photothermal nanomaterials for the comminution of kidney stones | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $269,503 | September 1, 2024 | August 31, 2029 | HOULIHAN, IAN | reporter.nih.gov |
| Nanoparticle-mediated treatment for bone metastasis | NIH | National Cancer Institute | 2021 | $268,394 | May 4, 2016 | April 30, 2024 | LABHASETWAR, VINOD D | reporter.nih.gov |
| Cost-effectiveness and efficacy of a combined intervention to facilitate motor recovery following stroke | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $267,172 | August 2, 2018 | January 31, 2024 | LINDER, SUSAN MARIE | reporter.nih.gov |
| Translating Genetic Risk Factors to Therapies: From Big Data to Druggable Targets | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $253,497 | July 1, 2021 | June 30, 2026 | SHAW, BENJAMIN C. | reporter.nih.gov |
| Ferroptosis in drug resistant glioma | NIH | National Cancer Institute | 2025 | $249,000 | September 19, 2023 | August 31, 2028 | TIEK, DEANNA MARIE | reporter.nih.gov |
| The role of neuronal activity on retinal angiogenesis and blood-retina barrier (BRB) maturation | NIH | National Eye Institute | 2025 | $248,999 | May 1, 2025 | April 30, 2028 | BISWAS, SAPTARSHI | reporter.nih.gov |
| Developing shared medical appointments for informal caregivers of Alzheimer’s and Dementia patients to improve knowledge, communication, and advanced planning | NIH | National Institute on Aging | 2024 to 2025 | $247,867 | August 15, 2024 | April 30, 2029 | ALPERT, JORDAN M | reporter.nih.gov |
| Air Pollution, Environmental Injustice and Progressive Pulmonary Fibrosis | NIH | National Institute of Environmental Health Sciences | 2025 | $241,811 | January 1, 2025 | December 31, 2029 | MACMURDO, MAEVE GEORGIA | reporter.nih.gov |
| Applying Innovative Artificial Intelligence Approaches to a Large Sleep Physiologic Biorepository to Integrate Sleep Disruption in Cardiovascular Risk Calculation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $241,500 | September 1, 2023 | August 31, 2025 | LIMA DINIZ ARAUJO, MATHEUS | reporter.nih.gov |
| Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists | NIH | National Institute on Drug Abuse | 2023 | $241,500 | April 1, 2022 | March 31, 2025 | HAOUZI, PHILIPPE A | reporter.nih.gov |
| Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors | NIH | National Institute of Mental Health | 2025 | $241,500 | December 16, 2024 | November 30, 2029 | LOUVEAU, ANTOINE | reporter.nih.gov |
| Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma | NIH | National Cancer Institute | 2021 to 2022 | $240,900 | March 1, 2021 | February 28, 2023 | BAYIK WATSON, DEFNE | reporter.nih.gov |
| A Daily, Digital Mindfulness-Based Intervention for Depressive Symptoms After Serious Illness | NIH | National Center for Complementary & Integrative Health | 2025 | $240,840 | August 22, 2025 | March 31, 2030 | SIWIK, CHELSEA JANE | reporter.nih.gov |
| Analysis of C9ORF72-associated poly (GR) interactions on BAF chromatin remodeling complex structure and function | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $236,668 | December 15, 2024 | November 30, 2029 | LOPEZ GONZALEZ, RODRIGO | reporter.nih.gov |
| Healthy Aging in People with Epilepsy Program (HAP-E): Closing the Gap in Geriatric Epilepsy Care | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $207,002 | August 1, 2025 | July 31, 2030 | REYES, ANNY | reporter.nih.gov |
| MRI Predictors of Outcome after Arthroscopic Partial Meniscectomy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $206,144 | August 1, 2019 | July 31, 2022 | SUBHAS, NAVEEN | reporter.nih.gov |
| MCEMP1 is an adaptor for KIT receptor for mast cell proliferation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $203,520 | April 1, 2021 | January 22, 2024 | CHOI, YOUN JUNG | reporter.nih.gov |
| Evaluating the adoption, implementation, and maintenance of a cervical precancer treatment in El Salvador | NIH | National Cancer Institute | 2025 | $202,487 | September 11, 2025 | August 31, 2027 | SOLER, MONTSERRAT | reporter.nih.gov |
| Unraveling the PTEN Interactome: Modeling Structural and Functional Dynamic Network Architecture for Therapeutic Modulation in Cancer and Autism | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $200,000 | July 1, 2021 | June 30, 2024 | SMITH, IRIS NIRA | reporter.nih.gov |
| IRF3 activation promotes fibrotic liver injury in alcohol-associated-liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $191,940 | August 16, 2021 | April 16, 2024 | DU ROSS, CHRISTINA KATHERINE | reporter.nih.gov |
| Modulation of Monocyte and T Cell Functions by Immune Inhibitory Receptors during Subclinical Malaria | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $184,109 | December 19, 2024 | November 30, 2026 | DOBBS, KATHERINE ROSE | reporter.nih.gov |
| Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease | NIH | National Institute on Aging | 2021 | $173,933 | May 1, 2017 | April 30, 2024 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| The Effects of Reduced ACL Stiffness on Dynamic In Vivo Joint Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $167,265 | July 19, 2019 | October 21, 2022 | BEVERIDGE, JILLIAN ELIZABETH | reporter.nih.gov |
| The role of HMGB1 in gut antimicrobial defense and the pathophysiology of inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $166,212 | July 1, 2017 | June 30, 2023 | MESSER, JEANNETTE SOPHIA | reporter.nih.gov |
| Matrix-Myosin II Interactions Drive Fibrosis in Idiopathic Pulmonary Fibrosis. | NIH | National Heart, Lung, and Blood Institute | 2021 | $163,037 | July 11, 2017 | June 30, 2023 | SOUTHERN, BRIAN DERRIS | reporter.nih.gov |
| Develop a human liver system to study SLC25A13 mutations in citrin deficiency | NIH | National Center for Advancing Translational Sciences | 2023 | $161,000 | August 1, 2023 | July 31, 2024 | WU, XIANFANG | reporter.nih.gov |
| Connexin 43 drives glioblastoma cancer stem cells through a WNK1 signaling axis | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $161,000 | August 15, 2024 | July 31, 2026 | MULKEARNS-HUBERT, ERIN E. | reporter.nih.gov |
| Metabolic basis of sarcopenia in alcohol-related liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $161,000 | September 15, 2025 | August 31, 2027 | WELCH, NICOLE | reporter.nih.gov |
| Modifiable Determinants of Disparities in Multiple Myeloma Treatment Patterns | NIH | National Cancer Institute | 2023 | $160,018 | February 1, 2023 | January 31, 2024 | GASOYAN, HAMLET | reporter.nih.gov |
| Internalization of dead cells governs intestinal stem cell activity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $155,348 | December 1, 2023 | November 30, 2026 | ZHOU, JULIE Y. | reporter.nih.gov |
| Deep Learning of Renal Scans and Kidney Ultrasounds in Children with Antenatal Hydronephrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $155,011 | March 15, 2025 | January 31, 2030 | WEAVER, JOHN | reporter.nih.gov |
| Nocturnal hypoxemia dysregulates skeletal muscle protein homeostasis in COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $151,578 | January 1, 2025 | December 31, 2029 | ATTAWAY, AMY | reporter.nih.gov |
| The role of retrotransposonable elements in neurodevelopment and disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $151,040 | March 1, 2024 | February 28, 2026 | TALLEY, MARY | reporter.nih.gov |
| Sex Differences in Blood-Brain and Blood-Tumor Barrier Dynamics in Glioblastoma | NIH | National Cancer Institute | 2022 to 2023 | $142,152 | December 10, 2021 | June 9, 2023 | SPROWLS, SAMUEL ADAM TYLER | reporter.nih.gov |
| Gender-based precision care for asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $134,136 | August 7, 2017 | June 27, 2023 | ZEIN, JOE | reporter.nih.gov |
| Population Assessments of Aggregate Genetic Risk for DilatedýCardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2025 | $133,337 | August 15, 2021 | July 31, 2026 | ARAGAM, KRISHNA G | reporter.nih.gov |
| Platelets as therapeutic and diagnostic entity in fibromuscular dysplasia | NIH | National Heart, Lung, and Blood Institute | 2025 | $118,919 | August 1, 2025 | June 30, 2027 | AGGARWAL, ANU | reporter.nih.gov |
| Altered RPE matrix in Sorsby Fundus Dystrophy leads to metabolic dysfunction | NIH | National Eye Institute | 2021 to 2023 | $118,363 | September 10, 2021 | September 9, 2024 | GRENELL, ALLISON BROOKE | reporter.nih.gov |
| Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $113,868 | August 18, 2021 | July 31, 2026 | HASSAN, NOHA ABDELWAHAB HASSAN ALI | reporter.nih.gov |
| Polyamines drive glioblastoma progression | NIH | National Cancer Institute | 2021 to 2023 | $107,641 | July 26, 2021 | April 30, 2024 | KAY, KRISTEN | reporter.nih.gov |
| Host and microbe-dependent mechanisms of enhanced autoimmune susceptibility driven by checkpoint inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $107,232 | December 1, 2023 | November 30, 2026 | SALAZAR, VANESSA | reporter.nih.gov |
| Endogenous memory T cell mediated rejection of high-risk cardiac allografts | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $106,668 | September 1, 2023 | August 31, 2025 | KORITZINSKY, ERIK HARRISON | reporter.nih.gov |
| Characterizing the role of mitochondrial DNA mutations on retinal degeneration. | NIH | National Eye Institute | 2024 to 2025 | $98,512 | February 1, 2024 | January 31, 2027 | STURGIS, JOHNATHON BRIAN | reporter.nih.gov |
| Ribonucleotide Reductase as a Driver of Breast Cancer Aggressiveness | NIH | National Cancer Institute | 2024 to 2025 | $97,932 | May 1, 2024 | April 30, 2026 | BRZOZOWSKI, TAYLOR LYNN | reporter.nih.gov |
| Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | NIH | National Institute of Dental & Craniofacial Research | 2021 | $94,042 | August 1, 2020 | April 30, 2022 | CHEN, WEIQIANG | reporter.nih.gov |
| Bacterial Rogue Methyltransferases Inducing Human Epimutations | NIH | National Cancer Institute | 2021 to 2022 | $91,888 | June 1, 2021 | August 31, 2022 | FINK, EMILY E | reporter.nih.gov |
| Ethics of the Choice of Invasive versus Non-invasive Neurosurgery: DifferentStakeholders' Perspectives, Surgical Decision-making, and Impact on Patient Sense ofControl | NIH | National Institute of Mental Health | 2022 | $81,305 | July 21, 2020 | June 30, 2023 | KUBU, CYNTHIA M. S. | reporter.nih.gov |
| Shared Mechanisms and Markers of Renal Injury and Neurocognitive Impairment in People with HIV | NIH | National Institute of Mental Health | 2021 | $80,500 | August 1, 2020 | July 31, 2022 | KALLIANPUR, ASHA R | reporter.nih.gov |
| Development of motion correction algorithms for functional MRI data using a custom simultaneously excited multi-slice MRI acquisition with prospectively injected motion | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $80,500 | February 1, 2025 | January 31, 2027 | SHIN, WANYONG | reporter.nih.gov |
| Identifying imaging biomarkers of cognitive impairment in autoimmune encephalitis | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $80,500 | August 6, 2025 | July 31, 2027 | KUNCHOK, AMY | reporter.nih.gov |
| A Hyper-Thrombotic State and Immunosuppression in GBM | NIH | National Cancer Institute | 2024 | $75,928 | December 1, 2024 | November 30, 2027 | SLOAN, ANTHONY ROBERT | reporter.nih.gov |
| Dissecting the roles of a novel immune-checkpoint receptor complex in driving T cell dysfunction in cancers | NIH | National Cancer Institute | 2021 to 2022 | $75,699 | August 1, 2021 | May 18, 2023 | GILMOUR, CASSANDRA | reporter.nih.gov |
| Human iPSC-derived Podocytes to Study APOL1 High-Risk Variants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $74,936 | September 1, 2023 | August 31, 2025 | HAINES, LAUREN ELIZABETH | reporter.nih.gov |
| Role of SerpinB3 in glioblastoma cancer stem cells | NIH | National Cancer Institute | 2021 to 2022 | $71,588 | January 1, 2021 | June 30, 2022 | LAUKO, ADAM | reporter.nih.gov |
| C-Type Lectins and Immune Surveillance in ALD | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $61,569 | September 1, 2021 | August 31, 2022 | KIM, ADAM | reporter.nih.gov |
| Elucidating a novel metabolic mechanism of glucosamine-driven treatment resistance in castration-resistant prostate cancer through stimulation of 3b-HSD1-mediated DHEA metabolism | NIH | National Cancer Institute | 2022 | $61,275 | June 1, 2022 | April 7, 2023 | VALLE, SHELLEY | reporter.nih.gov |
| Clinical Scholars Career Development Program (CSCDP) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $60,000 | February 1, 2024 | January 31, 2027 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Role of Hyperglycemia/Hyperinsulinemia in the Breakdown of the Blood Retinal Barrier in Diabetic Retinopathy | NIH | National Eye Institute | 2024 | $48,974 | March 1, 2024 | February 28, 2027 | HERNANDEZ, KAREN | reporter.nih.gov |
| Optical monitoring of the role of neurogenesis in epileptogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $47,414 | March 5, 2021 | December 2, 2021 | ROGERS, MORGAN | reporter.nih.gov |
| Investigating the role of sulfide oxidation and declining hydrogen sulfide in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $43,138 | June 2, 2025 | May 31, 2028 | PONTI, ANDRAS KRISTOPHER | reporter.nih.gov |
| SMARCA5 Inhibition as a Therapeutic Target for Glioblastoma | NIH | National Cancer Institute | 2025 | $41,876 | December 1, 2025 | November 30, 2027 | GUTHRIE, MOLLY | reporter.nih.gov |
| Research and Education towards Solutions for Late effects to Innovate, Excel, and Nurture after chronic Graft-versus-Host Disease (RESILIENT after cGVHD) | NIH | National Heart, Lung, and Blood Institute | 2024 | $36,500 | January 1, 2024 | December 31, 2024 | ROTZ, SETH J | reporter.nih.gov |
| Clinician Scholar Career Development Program (CSCDP) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $30,000 | July 1, 2019 | June 30, 2023 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | NIH | National Institute on Aging | 2022 | $28,267 | September 15, 2017 | April 30, 2018 | YAN, RIQIANG | reporter.nih.gov |
| The 6th Annual International PTEN Symposium: From Patient-Centered Research to Clinical Care | NIH | National Center for Advancing Translational Sciences | 2023 | $16,841 | March 20, 2023 | February 29, 2024 | ENG, CHARIS | reporter.nih.gov |
| 4th Annual International PTEN Symposium: From Patient-Centered Research to Clinical Care | NIH | National Center for Advancing Translational Sciences | 2021 | $5,000 | March 10, 2021 | March 9, 2022 | ENG, CHARIS | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 217 | $118,611,657 | 0 | $0 |
| 2024 | 226 | $121,208,364 | 0 | $0 |
| 2023 | 238 | $136,506,595 | 0 | $0 |
| 2022 | 241 | $125,295,908 | 0 | $0 |
| 2021 | 221 | $114,027,783 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Neurosciences
- Genetics
- Brain Disorders
- Rare Diseases
- Cancer
- Prevention
- Translational Research
- Neurodegenerative
- Biotechnology
- Aging
- Bioengineering
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.